Successful management of post-COVID-19 acanthamoebic encephalitis
- PMID: 34302963
- PMCID: PMC8295052
- DOI: 10.1016/j.ijid.2021.07.046
Successful management of post-COVID-19 acanthamoebic encephalitis
Abstract
Acanthamoebic encephalitis is a rare and highly fatal disease that has no standard management protocol. Coronavirus disease 2019 (COVID-19) causes immune dysfunction and may predispose patients to this infection. The present study describes successful management of acanthamoebic encephalitis in a young male who recently recovered from COVID-19 using a combination of medical and surgical approaches. A combination of miltefosine with other agents with trophicidal and cysticidal activities should be used in the regimen. Surgical excision of the abscess should be undertaken whenever feasible.
Keywords: Acanthamoeba; COVID-19; acanthamoebic encephalitis; miltefosine.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
The authors declare that they have no known competing interests that influenced the work reported in this paper.
Figures
Comment in
-
Acanthamoeba species from a post-covid patient with CSF rhinorrhea; a next possible post covid menace? A case report.Indian J Med Microbiol. 2023 Mar-Apr;42:100-102. doi: 10.1016/j.ijmmb.2022.09.014. Epub 2022 Oct 14. Indian J Med Microbiol. 2023. PMID: 36244850 Free PMC article.
References
-
- Acanthamoeba - Granulomatous Amebic Encephalitis (GAE); Keratitis | Acanthamoeba | Parasites | CDC. n.d. https://www.cdc.gov/parasites/acanthamoeba/index.html (accessed June 6, 2021).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
